ARX and mitochondrial disease: Recently, trio-WGS was performed in an Australian cohort of 40 pediatric patients with clinical features suggestive of mitochondrial disease reaching a definitive molecular diagnosis in 55% of cases; moreover, three potential novel genes (ARX, NBAS and SKIV2L) associated to mitochondrial disease were identified [83].